Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoproliferative Disorders × enzalutamide × Clear all

Sponsor

Conditions

Prostatic Neoplasms 67 Breast Neoplasms 9 Neoplasm Metastasis 7 Prostatic Neoplasms, Castration-Resistant 6 Neoplasms 5 Metastatic Castration-resistant Prostate Cancer 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Prostate Cancer Metastatic 3 Metastatic Castration Resistant Prostate Cancer 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Metastatic Hormone Sensitive Prostate Cancer 2 Melanoma 2 Bulbo-Spinal Atrophy, X-Linked 2 mCRPC 1 Urinary Bladder Diseases 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Ureteral Diseases 1 Solid Tumours 1 Small Cell Lung Carcinoma 1 Seizures 1 Salivary Cancer 1 Recurrent Endometrial Endometrioid Adenocarcinoma 1 Pancreatic Neoplasms 1 Non-metastatic, Hormone naïve Prostate Cancer 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms, Squamous Cell 1 Metastatic Progressive Castration-resistant Prostate Cancer 1

Interventions

blinatumomab 6 Rituximab 4 Cyclophosphamide 4 Tacrolimus 3 ponatinib 2 fludarabine 2 denileukin diftitox 2 Vorinostat 2 Vincristine 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Methotrexate 2 Everolimus 2 Etoposide 2 Doxorubicin 2 Darbepoetin alfa 2 Cytarabine 2 Busulfan 2 Brentuximab Vedotin 2 Antilymphocyte Serum 2 Alemtuzumab 2 tetulomab tetraxetan lu-177 1 ruxolitinib 1 pegaspargase 1 ibrutinib 1 ibritumomab tiuxetan 1 fludarabine phosphate 1 ferrous sulfate 1 ferric gluconate 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡